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Drug therapy may be effective in controlling symptoms but the frequent coexistence of
endometriosis and the lack of controlled studies make their efficacy difficult to quantify.
Danazol IUD has been shown to reduce symptoms. Conservative surgery involving endo-
myometrial ablation, laparoscopic myometrial electrocoagulation or excision has proven to
be effective in more than 50% of patients, although follow up has been restricted to three
years. Arterial uterine artery embolization is a new technique which may be tried before con-
sidering hysterectomy. Hysterectomy may still be necessary in severe cases of adenomyosis.
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INTRODUCTION
The treatment of adenomyosis has been limited by
the difficulty and delay associated with the dia-
gnosis, often not until after hysterectomy. Magnetic
resonance imaging, high resolution vaginal ultra-
sound and uterine biopsy has improved early
detection of adenomyosis [1].
Diagnosis of the extent and localization of the
disease is difficult, even with magnetic resonance
imaging (MRI), colour doppler vaginal ultrasound
and uterine biopsy techniques [2-9]. MRI is the
most sensitive test for detection of adenomyosis
but it is also the most expensive, limiting access
to affluent health care systems [8]. Uncertainty in
defining the site and more particularly the extent
of adenomyosis make it difficult to determine the
feasibility and accuracy of complete excision when
conserving the uterus. This is one reasonwhy hyster-
ectomy has remained the most popular operation
for adenomyosis.CA125 may be useful in diagnosis
or determining the extent of the disease [10,11].
In subfertile women, under the age of 30 years,
with dysmenorrhoea and menorrhagia, 28 of 56
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women having MRI and uterine histology have
adenomyosis [12].
One of the difficulties assessing results of
therapy is the lack of certainty of diagnosis, even
with histology, because of false negatives, and
uncertainty of the MRI criteria for diagnosis.
The specificity of the diagnosis by MRI, has
been determined by a junctional zone thicker than
5mm. Thickness greater than 5mm has been
found in 40% of normal subjects having serial
MRI measurements which also showed thicken-
ing up to 12mm and focal myometrial bulging
which may result from uterine contractions [13].
Myometrial changes in thickness, nodularity and
asymmetry, and increased vascularization may be
seen at MRI and sensitive vaginal ultrasound.
Drug therapy may be effective in controlling
symptoms but the frequent coexistence ofendomet-
riosis and the lack of controlled studies make their
efficacy difficult to quantify. Danazol IUD has
been shown to reduce symptoms.
SPECIFIC ENDOSCOPIC SURGICAL
TECHNIQUES
The choice of a suitable surgical procedure
depends upon the site and extent of disease, the
age of the patient, the desire for future pregnancy,
the patient’s desire for certain cure or not, and the
surgical skill of the gynaecologist.
Endo-myometrial Ablation/Resection
Endo-myometrial resection is most suited to
patients with disease limited to the endo-myomet-
rial junction as menstrual symptoms may be
reduced and the pathology may be removed. It
may also be useful when adenomyosis is present
in the outer myometrium as laparoscopic myomet-
rial excision alone may not cure menstrual
symptoms, either because excision may be incom-
plete or the menstrual symptoms are not caused by
the outer myometrial adenomyosis. Desire for a
future pregnancy contraindicates endo-myometrial
resection.
Technique
The technique of endometrial ablation has been
well described. If MRI or ultrasound shows the
extent and site of endo-myometrial distortion
the procedure can be modified to include 2-3mm
ofmyometrium in the affected areas. The whole of
the endometrium should be removed as menorr-
hagia may be due to factors other than the adeno-
myosis. Deeper myometrial removal or ablation
carries the risk of causing increased bleeding as
significant arteries are situated about 5mm deep
to the myometrial surface. Histology of the excised
myometrial fragments may help to confirm or
refute the diagnosis.
When endo-myometrial resection has been per-
formed as a single operative procedure, menstrual
symptoms have been controlled in 55% of women
for at least 2 years (Table I).
Laparoscopic Myometrial Electrocoagulation
Electrocoagulation has the capability of shrinking
adenomyosis by causing necrosis. The technique
has been applied to localized or extensive disease
TABLE Results of conservative surgery, 1991-97
Symptom free
N 6 mths 24 mths
Hospital stay
(days)
Complications
Endo-myometrial resection 18
Myometrial electrocoagulation 11
Myometrial excision 25
Subsequent hysterectomy
12 10(55%)
7 6(55%)
20 16 (64%)
10/54(18.5%)
1-2
1-3
0
0
3*
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[1]. The adenomyosis can be detected by MRI,
vaginal ultrasound, inspection of the uterus at
laparoscopy, myometrial needling, or manual
palpation during gasless laparoscopy to detect
differences in consistency between normal and
abnormal tissue. Electrocoagulation may be
less accurate than surgical excision as electrical
conduction in the abnormal tissue may be incom-
plete and this cannot be checked at the time of
surgery, It may also reduce the strength of the
myometrium by replacing abnormal myometrium
with scar tissue. The width of the scar may
be more extensive than after surgical excision
when close apposition of normal myometrium is
achieved.
Extensive myometrial electrocoagulation has
been performed in two women aged 42 and 46
years with extensive adenomyosis on the anterior
and posterior uterine walls; drug therapy had
failed, excision was not feasible, and hysterectomy
was not wanted. Two years later both are free
of severe menstrual pain and bleeding. Diffuse
multifocal electrocoagulation of the myometrium
containing adenomyosis may be sufficient to
control symptoms. The risk of uterine rupture
following extensive electrocoagulation is demon-
strated by the following experience. One patient
had two laparoscopic procedures involving
myometrial electrocoagulation, one of which
was also associated with excision of an elevated
adenomyotic area. The patient was aware of
the risk of uterine rupture, she had not res-
ponded to GnRH analogue therapy, was not
suitable for extensive myometrial excision and
had refused hysterectomy as she wished to
attempt conception even if this failed. A sub-
sequent pregnancy resulted in uterine rupture at
12 weeks.
Electrocoagulation is best suited to women
over 40 years of age, who do not wish to conceive,
and who wish to avoid more extensive surgery
such as excision or hysterectomy. Even if recur-
rence occurs the procedure may be repeated
until the onset of the menopause when symptoms
cease.
Technique
Uterine manipulation with a Valtchev manipulator
improves access to the diseased areas by facilitat-
ing antero-posterior and lateral movement of the
uterus.
Vasoconstricting agents such as adrenaline and
vasopressin are not used routinely as excessive
bleeding has not been experienced and the blanch-
ing of the myometrium after vasoconstriction
makes it difficult to determine the devascularizing
effect of electrocoagulation or uterine vessel
closure.
Closure of the ascending uterine artery may be
performed if technically feasible, future pregnancy
is not wanted, and the site of the adenomyosis is in
the upper uterine body. Bipolar forceps, clips or
suture ligation may be used to close the uterine
vessels.
Electrocoagulation of the adenomyosis may be
carried out with unipolar or bipolar needles, using
50 watts coagulation current. Bipolar needles have
a theoretical advantage of concentrating current
between the two needles, but their effectiveness is
diminished by the tendency of the two needles to
move close together as they penetrate the myomet-
rium. Additionally, the area of coagulation may
spread outwards from each needle, simulating the
effect of monopolar electrocoagulation.
The extent of coagulation can be controlled by
reducing the current strength and changing the
time the needle(s) are held in position. In order to
reduce the possibility of severe surface necrosis
and carbonization, either of which may encourage
future adhesion formation, the insulated part of
the needle is buried a few millimetres below the
uterine surface before electrocoagulation is com-
menced. The insulation on the bipolar needle can
be extended so that the active part of the electrode
is shortened in order to avoid surface coagulation
and necrosis. Needle punctures are made at 1-2 cm
intervals, depending on the spread of the coagu-
lative effect. The depth of needle puncture may
vary, depending on the thickness of the adeno-
myotic myometrium determined preoperatively92 C. WOOD
by ultrasound or MRI. If hysteroscopic endo-
myometrial ablation has also been carried out, the
depth of laparoscopic needle electrocoagulation
may be reduced.
Hysteroscopic endo-myometrial ablation may
be performed in association with myometrial elec-
trocoagulation as menorrhagia and dysmenor-
rhoea may not be related to the presence of outer
myometrial adenomyosis.
Sterilization should be offered to all women
having myometrial electrocoagulation because of
the possible future risk of uterine rupture in preg-
nancy.
Bleeding is rare during electrocoagulation and
can be controlled by using a vasopressor or myo-
tonic drugs such as adrenaline, oxytoxin or vaso-
pressin, or by bipolar electrocoagulation or suture
ligation.
Patients are usually in hospital for 8-24 hours.
No complications have been observed including
post-operative infection, bleeding or subsequent
adhesion formation.
The result of the surgery may be assessed by
symptom relief and MRI or vaginal ultrasound.
Loss of features of adenomyosis including reduc-
tion of myometrial thickness, reduced vascularity
and normal myometrial appearance have all been
observed. Symptom relief may occur and persist
for several years in the presence of reduced ultra-
sound evidence of adenomyosis.
Myometrial Excision
Adenomyosis may be excised if it does not
involve the major portion of the uterus, and its
extent can be defined as previously described. The
technique is also suitable for adenomyomas
where the margins of the pathology are more
easily defined. It may be useful in women wishing
to become pregnant, providing sufficient myo-
metrium remains to allow uterine expansion and
term pregnancy and the scar formed after
excision is not wide or shallow. MRI or colour
doppler ultrasound after surgery should be used
to check both for cure, the width and depth of
scar, and the possible association of residual
adenomyosis close to the scar, before attempts
at conception are advised.
Technique
Preoperative GnRH analogues or Danazol may
reduce uterine vascularity, correct anaemia if the
patient has severe menorrhagia, and reduce oper-
ative bleeding which facilitates surgery by laparo-
scopy rather than laparotomy. Vasoconstrictor
drugs may also reduce bleeding at the time of
surgery.
Prior to myometrial excision, as with electrosur-
gical coagulation, the uterine blood supply may be
reduced by suture or clip ligation or bipolar dia-
thermy of the ascending uterine vessels in women
not concerned with fertility. Apart from reducing
bleeding during surgery the reduction in blood
flow may reduce future growth or development
of adenomyosis.
Two associated surgical procedures may be
offered, sterilization to prevent conception and
hysteroscopic endomyometrial ablation if menor-
rhagia is present, and fertility is not required.
Minilaparotomy may be required to facilitate
myometrial excision. Laparotomy instruments
can gain entry to the abdomen through a 2-4cm
incision which may be sufficient to remove and
repair areas of myometrium up to 6 8 cm.
A Valtchev uterine manipulator is used to posi-
tion the adenomyotic areas as close as possible to a
laparoscopic or minilaparotomy incision. Some-
times a myoma screw may stabilize the diseased
area and aid excision. A diathermy spoon using
100 watts monopolar current, or scalpel, are suit-
able for excision. The spoon has the advantage of
cutting effectively with the sharp end close to the
tissue, and coagulating vessels when the convex
curve of the spoon compresses the vessel. When
the tissue is very firm the scalpel may be prefer-
able, providing more effective and rapid excision.
The margin of the adenomyosis may be deter-
mined by change in appearance, vascularity or
consistency; finger palpation may be an advantage.DIFFICULTY IN DIAGNOSING ENDOMETRIOSIS 93
Closure of incisions longer than 5-6cm may
require laparotomy instruments as excision of a
significant volume of myometrium increases the
tension at the myometrial edges which may have
to be stretched to close the defect. If the uterine
wound is brought into a minilaparotomy incision,
the defect can be closed more easily and quickly.
Absorbable sutures (No. 1) are used in one or
more layers. If there is a large defect a single layer
through and through suture may best approximate
the wound, acting as a tension suture, and because
of the increased thickness of the whole myomet-
rium, it is less likely to tear as tension is increased
to attain closure.
Anti-adhesives such as Interceed(R) and Goretex(R)
membrane may be used. The frequency of
adhesions after excision of adenomyosis has not
been reported. Interceed may be used if perfect
haemostasis is obtained. Application of Surgicel(R)
prior to Interceed may improve haemostasis and
allow the use of Interceed. If bleeding persists
Goretex can be stapled over the wound. This need
not be removed unless pregnancy is planned. Uter-
ine enlargement may displace the membrane from
the uterus which may attach to other organs.
Hysterectomy may still be necessary in severe
cases of adenomyosis. Severity of adenomyosis is
related to late diagnosis. Early diagnosis may
improve treatment and investigations are indicated
in women with menstrual pain or menorrhagia not
responding to drug therapy.
Results of Conservative Surgery
Conservative surgery in a personal series of 62
women with adenomyosis and diagnosed by vagi-
nal ultrasound with doppler assessment, percutan-
eous uterine needle biopsy, and histology of
excised endo-myometrial or needle myometrial
biopsy at the time of hysteroscopy or laparoscopy,
resulted in 63% of women being symptom free 2
years later and 12% requiring hysterectomy during
the same time period because of persistence or
recurrence of severe symptoms. Each of the tech-
niques had a success rate greater than 50%. Nine
of 16 women attempting pregnancy conceived, 4 of
7 after myometrial electrocoagulation and 5 of 9
after myometrial excision. One woman who had
two electrocoagulation treatments, including
one associated myometrial excision, subsequently
ruptured her uterus in the twelfth week of preg-
nancy.
MRI and uterine biopsy were used to diagnose
nodular adenomyosis by Phillips et al. [14].
Preoperative GnRH analogue, endomyometrial
resection and bipolar coagulation were used in
14 women. One year after treatment menorrhagia
was cured in 12 and dysmenorrhoea in 8. Two
proceeded to hysterectomy. The advantage of
preoperative use of GnRH analogue was shown
by a 50.8% mean reduction of uterine volume after
leuprolide acetate treatment for 3 months.
GnRH Analogues
A GnRH analogue, leuprolide acetate has been
used to produce a constant hypoestrogenic state
in a woman with histologically proven adenomyo-
sis [14]. Dysmenorrhoea and desire for conception
were the two complaints. This produced amenor-
rhoea, control of pain and uterine shrinkage, and
conception resulted.
A pure antiestrogen may offer some advantage
in the treatment of adenomyosis and trials are
planned to assess its usefulness in the human.
Topical Danazol/Progestogen Therapy
Adenomyosis has been treated by 200mg of dana-
zol contained in an intrauterine device (DIUD)
[15]. Blood danazol levels are undetectable, ovula-
tion was not inhibited, and side effects did not
occur. The DIUD was effective in 9 of 10 cases in
reducing uterine size and dysmenorrhoea and
pregnancy occurred in 3 cases after removal of
the DIUD. Another study of the DIUD containing
300tg of danazol produced similar results over
6-12 months [10]. Symptoms improved in more
than 70% of patients especially for dysmenor-
rhoea, the DIUD was shown to be active after94 C. WOOD
12 months use, mean CA125 levels decreased from
295U/m1 to 115U/m1, and mean uterine vol-
ume decreased from 369cm to 264cm3. Using
the DIUD in Australian women 3 of 4 expelled
the DIUD and a larger IUD would be required to
test its efficacy.
The levonorgestrel intrauterine device (LNIUD)
has proven to be effective not only as a contra-
ceptive but also in the control of menorrhagia. Its
action is to produce an atrophic endometrium. It
may be useful in the control of menorrhagia in the
presence of adenomyosis, and possibly the reduc-
tion of dysmenorrhoea. The antioestrogenic effect
may reduce the growth of the adenomyotic tissue.
A study of 25 women with menorrhagia associated
with adenomyosis diagnosed by vaginal ultra-
sound has shown that 23 had relief of menorrhagia
persisting for year after use of the LNIUD
[16]. Reduction of menstrual pain was less
frequent. Spotting in the first 3 months was the
most common side effect, one patient asking to
have the device removed because of this. Six
patients reported headaches, three breast tender-
ness, six greasy hair, seborrhoea or acne, and seven
weight gain. Spotting was well tolerated.
Arterial Embolization
Arterial uterine artery embolization has the poten-
tial to reduce blood flow to part or the whole of
the uterus. Two patients with diffuse adenomyosis
have been treated by embolization with cure or
control of menstrual pain and menorrhagia; follow
up is only short term. Angiography and doppler
ultrasound demonstrates more than 50% reduc-
tion of uterine blood flow. The technique will be
tried on all patients who would otherwise require
hysterectomy. In both patients the posterior
myometrial thickness was reduced by 45 and
58%, small myometrial cystic spaces were present
in one and myometrial scarring increased in the
other.
The major advantage of arterial embolization is
that the angiogram localizes the site of adenomyo-
sis by indicating increased vascularization often
associated with adenomyotic areas, which can then
be targeted by precise embolization of the arteries
supplying the involved areas.
It may not be suitable for patients wishing to
conceive, as large areas of scarred myometrium
may weaken the uterus and result in uterine
rupture in pregnancy.
The limitation of uterine artery embolization is
the possibility of early regrowth of the adenomyo-
sis and the limited availability of the technique. Its
increasing use in treating certain types of fibroids
may encourage exploration of the techniques’
effectiveness or not in adenomyosis. Complica-
tions are unproven. The cure rate for menorrhagia
in women with fibroids is more than 50% [17,18].
Pain may occur for up to 1-2 months which is
similar to that after laparoscopic excision of
adenomyosis. The technique has to be done by
skilled radiologists e.g. those already treating brain
aneurysms. Two cases in a review of all 2000 cases
performed in the USA resulted in ovarian failure
in three patients.
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